Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy
. Int J Radiat Oncol Biol Phys 2011;79:363-70http://dx.doi.org/10.1016/j.ijrobp.2009.10.035.
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy
or brachytherapy, with and without neo-adjuvant androgen ablation: data from CaPSURE.
The Canadian Association of Radiation Oncology defines SBRT as the precise delivery of highly conformal and image-guided hypofractionated external beam radiotherapy
, delivered in a single or few fraction(s).
Radical retropubic prostatectomy (RRP) was associated with significantly more urinary incontinence and sexual dysfunction than was external beam radiotherapy
or brachytherapy, according to data that were presented at the meeting.
The multicenter, phase III trial also revealed that patients who received vaginal brachytherapy had significantly fewer episodes of diarrhea, and reported less restriction of their daily activities because of bowel problems, compared with those who underwent external beam radiotherapy
Of the patients enrolled, 68% were originally treated by radical prostatectomy, 10% by external beam radiotherapy
, 10% by brachytherapy, 7% by surgery and radiation, and 5% by cryotherapy.
External Beam Radiotherapy
, one of the segments analyzed and sized in this study, displays the potential to grow at over 4%.
Serum TSH and free T4 were estimated at 1 months, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months following completion of external beam radiotherapy
. The normal values used for our study were TSH 0.5-4.7 [micro]U/ml and free T4 0.8-2.7 ng/dl.
Based on type, the external beam radiotherapy
segment accounted for the largest share in 2016.
All patients received external beam radiotherapy
at a referral center with doses varying from 6 to 12 Gy.
[3,4] Various treatment modalities namely, chemotherapy, hormonal therapy, external beam radiotherapy
and bisphosphonate therapy are available therapeutic options for these patients.